Camascope, a leading provider of innovative care technology solutions, is pleased to announce the appointment of Kehan Zhou as the new Chief Executive Officer.
Kehan will be taking over from interim CEO Keith Crider, who provided valuable leadership during the transitional period. Keith will continue his role as a Director on the Camascope Board.
Kehan brings a wealth of experience as a tech entrepreneur and artificial intelligence expert, with a strong track record of disrupting industries through technology-driven solutions. Most recently, Kehan was the CEO of Terrascope, where he led a team of talented machine learning engineers in developing cutting-edge computer vision technology. This technology enabled the conversion of satellite images into valuable data, empowering government entities to make informed decisions and drive positive change.
Kehan's global perspective on innovation and entrepreneurship has been shaped by his experiences living and working in major cities such as New York, London, Los Angeles, Toronto, Montreal, and Beijing. His diverse background and expertise will play a crucial role in driving Camascope's strategic growth and continued success.
Kehan commented on his appointment:
"I am honoured to lead Camascope during this exciting phase of growth and innovation. With our dedicated team and innovative care technology solutions, we have a tremendous opportunity to enhance the quality of care and make a meaningful impact on the lives of individuals and communities. I look forward to working closely with the team, our clients, and partners to drive positive change in the care sector."
About Camascope: Camascope is a leading provider of eMAR (electronic medication administration record). The system is designed to digitise and improve medication processes for care providers and pharmacies across the UK. Tens of thousands of service-users are benefiting from the Camascope system that integrates with care planning systems, such as Nourish, PCS, and KareInn, providing a centralised solution for all key medication and care activities.
